Thera-D 2000 Interactions
There are 76 drugs known to interact with Thera-D 2000 (cholecalciferol), along with 5 disease interactions. Of the total drug interactions, 11 are major, 64 are moderate, and 1 is minor.
- View all 76 medications that may interact with Thera-D 2000
- View Thera-D 2000 disease interactions (5)
Most frequently checked interactions
View interaction reports for Thera-D 2000 (cholecalciferol) and the medicines listed below.
- Aciphex (rabeprazole)
- Admelog (insulin lispro)
- Advair HFA (fluticasone / salmeterol)
- Align (bifidobacterium infantis)
- Allergy Relief Tablets (loratadine)
- amlodipine
- Aspir 81 (aspirin)
- aspirin
- atorvastatin
- atropine / diphenoxylate
- Avodart (dutasteride)
- azelastine nasal
- Basaglar (insulin glargine)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- calcium carbonate
- docusate
- escitalopram
- gabapentin
- hydroxychloroquine
- losartan
- magnesium citrate
- magnesium glycinate
- metoprolol
- Metoprolol Succinate ER (metoprolol)
- montelukast
- omeprazole
- trazodone
- valacyclovir
- valsartan
- Zoloft (sertraline)
Thera-D 2000 disease interactions
There are 5 disease interactions with Thera-D 2000 (cholecalciferol) which include:
More about Thera-D 2000 (cholecalciferol)
- Compare alternatives
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: vitamins
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.